mRNA COVID-19 Vaccination During Pregnancy
Cross-source consensus on mRNA COVID-19 Vaccination During Pregnancy from 1 sources and 4 claims.
1 sources · 4 claims
Dosage & preparation
Where it comes from
Other
Highlighted claims
- The study assessed mRNA COVID-19 vaccination during pregnancy in a large Quebec cohort from May 2021 to June 2023. — Safety of COVID-19 vaccines among pregnant individuals in Quebec, Canada: a population-based retrospective cohort study from the Canadian Immunization Research Network
- The final cohort included 140,073 singleton pregnancies, and 43.8% received at least one mRNA COVID-19 vaccine dose during pregnancy. — Safety of COVID-19 vaccines among pregnant individuals in Quebec, Canada: a population-based retrospective cohort study from the Canadian Immunization Research Network
- Vaccine exposure was defined as at least one mRNA COVID-19 dose from estimated conception through one day before delivery. — Safety of COVID-19 vaccines among pregnant individuals in Quebec, Canada: a population-based retrospective cohort study from the Canadian Immunization Research Network
- Women vaccinated only before conception or only postpartum were classified as unexposed. — Safety of COVID-19 vaccines among pregnant individuals in Quebec, Canada: a population-based retrospective cohort study from the Canadian Immunization Research Network